(Q34991484)

5 August 2017

1 reference

title

Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis (English)

1 reference

juvenile rheumatoid arthritis

5 August 2017

main subject

1 reference

0 references

1 reference

2

Gillian M Keating

1 reference

5 August 2017

Christine R Culy

1

1 reference

5 August 2017

publication date

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

62

1 reference

5 August 2017

issue

17

1 reference

5 August 2017

page(s)

2493-2537

1 reference

Juvenile rheumatoid arthritis: therapeutic perspectives

5 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200262170-00013

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides

21 January 2018

1 reference

12 December 2020

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

12 December 2020

Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.

1 reference

12 December 2020

Early rheumatoid arthritis: therapeutic strategies.

1 reference

12 December 2020

Diagnosis and management of psoriatic arthritis

1 reference

12 December 2020

Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period

1 reference

12 December 2020

Cachectin/tumour necrosis factor-alpha in the circulation of patients with rheumatic disease

1 reference

12 December 2020

Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001)

1 reference

12 December 2020

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

12 December 2020

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

12 December 2020

Medical management of children with juvenile rheumatoid arthritis

1 reference

12 December 2020

Preliminary definition of improvement in juvenile arthritis

1 reference

12 December 2020

1 reference

12 December 2020

Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

1 reference

12 December 2020

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

12 December 2020

Interventions for psoriatic arthritis.

1 reference

12 December 2020

Guidelines for the management of rheumatoid arthritis: 2002 Update

1 reference

12 December 2020

Juvenile arthritis--who gets it, where and when? A review of current data on incidence and prevalence.

1 reference

12 December 2020

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

12 December 2020

Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy

1 reference

12 December 2020

Consensus recommendations for the assessment and treatment of rheumatoid arthritis.

1 reference

12 December 2020

Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept

1 reference

12 December 2020

Juvenile chronic arthritis

1 reference

12 December 2020

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

12 December 2020

Prognostic factors in juvenile idiopathic arthritis

1 reference

12 December 2020

Tumour necrosis factor alpha and its soluble receptors in juvenile chronic arthritis

1 reference

12 December 2020

Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997

1 reference

12 December 2020

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

12 December 2020

Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters

1 reference

12 December 2020

Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis

1 reference

12 December 2020

1 reference

12 December 2020

Drug-induced systemic lupus erythematosus associated with etanercept therapy

1 reference

12 December 2020

Leflunomide: a review of its use in active rheumatoid arthritis

1 reference

12 December 2020

Onset of multiple sclerosis associated with anti-TNF therapy.

1 reference

12 December 2020

Etanercept-induced subacute cutaneous lupus erythematosus

1 reference

12 December 2020

A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis

1 reference

12 December 2020

Psoriatic arthritis (PSA)--an analysis of 220 patients

1 reference

12 December 2020

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

1 reference

12 December 2020

Soluble tumor necrosis factor receptors in human inflammatory synovial fluids

1 reference

12 December 2020

Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis

1 reference

12 December 2020

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

1 reference

12 December 2020

Immune function in patients with rheumatoid arthritis treated with etanercept

1 reference

12 December 2020

Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumour necrosis factor-alpha

1 reference

12 December 2020

Leukocytoclastic vasculitis due to etanercept

1 reference

12 December 2020

Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha

1 reference

12 December 2020

Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines

1 reference

12 December 2020

An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline

1 reference

12 December 2020

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

12 December 2020

The role of NSAIDs in psoriatic arthritis: evidence from a controlled study with nimesulide.

1 reference

12 December 2020

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

1 reference

12 December 2020

Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra

1 reference

12 December 2020

1 reference

12 December 2020

Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis

1 reference

12 December 2020

Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists

1 reference

12 December 2020

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

12 December 2020

Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies

1 reference

12 December 2020

Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial

1 reference

12 December 2020

Etanercept: a review of its use in rheumatoid arthritis

1 reference

12 December 2020

The pharmacokinetics of etanercept in healthy volunteers

1 reference

12 December 2020

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

12 December 2020

A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis. OMERACT Drug Safety Working Party

1 reference

12 December 2020

Psoriatic arthritis: a quantitative overview of therapeutic options. The Psoriatic Arthritis Meta-Analysis Study Group

1 reference

12 December 2020

Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis

1 reference

12 December 2020

Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy

1 reference

12 December 2020

Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients

1 reference

12 December 2020

Etanercept in the treatment of severe, resistant psoriatic arthritis: continued efficacy and changing patterns of use after two years.

1 reference

12 December 2020

Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice

1 reference

12 December 2020

Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model

1 reference

12 December 2020

Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis

1 reference

12 December 2020

Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures

1 reference

12 December 2020

"Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate

1 reference

12 December 2020

A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.

1 reference

12 December 2020

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study

1 reference

12 December 2020

1 reference

12 December 2020

The economic impact of the rheumatic diseases in the United States

1 reference

12 December 2020

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

12 December 2020

Decreased flares of rheumatoid arthritis during the first year of etanercept treatment: further evidence of clinical effectiveness in the "real world".

1 reference

12 December 2020

WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis

1 reference

12 December 2020

Prognostic factors in rheumatoid arthritis

1 reference

12 December 2020

The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence?

1 reference

12 December 2020

Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis

1 reference

12 December 2020

Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis

1 reference

12 December 2020

Mortality in rheumatoid arthritis

1 reference

12 December 2020

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

12 December 2020

Comparison of rheumatoid arthritis care costs in patients starting therapy with leflunomide versus etanercept.

1 reference

12 December 2020

The pharmacokinetics of etanercept in patients with heart failure

1 reference

12 December 2020

Early aggressive DMARD therapy: the key to slowing disease progression in rheumatoid arthritis

1 reference

12 December 2020

Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group.

1 reference

12 December 2020

Autoimmune skin rashes associated with etanercept for rheumatoid arthritis

1 reference

12 December 2020

Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes

1 reference

12 December 2020

Etanercept in the treatment of adult patients with Still's disease

1 reference

12 December 2020

Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis

1 reference

12 December 2020

Proposal to establish a register for the long term surveillance of adverse events in patients with rheumatic diseases exposed to biological agents: the EULAR Surveillance Register for Biological Compounds.

1 reference

12 December 2020

Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis

1 reference

12 December 2020

A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.

1 reference

12 December 2020

Can we predict aggressive disease?

1 reference

12 December 2020

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha

1 reference

12 December 2020

From wheels to feet: a dramatic response of severe chronic psoriatic arthritis to etanercept

1 reference

12 December 2020

Criteria for TNF-targeted therapy in rheumatoid arthritis: estimates of the number of patients potentially eligible

1 reference

12 December 2020

Patterns of cytokine production in psoriatic synovium

1 reference

12 December 2020

Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy

1 reference

12 December 2020

Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset

1 reference

12 December 2020

Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group

1 reference

12 December 2020

Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum

1 reference

12 December 2020

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis

1 reference

12 December 2020

The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis

1 reference

12 December 2020

Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor beta levels in rheumatoid arthritis

1 reference

12 December 2020

Drug treatment in children with juvenile rheumatoid arthritis. Past, present, and future.

1 reference

12 December 2020

A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency

1 reference

12 December 2020

Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid

1 reference

12 December 2020

Psoriatic arthritis. Historical background and epidemiology

1 reference

12 December 2020

Rheumatoid arthritis: pathogenesis and early recognition

1 reference

12 December 2020

Cytokine pathways and joint inflammation in rheumatoid arthritis

1 reference

12 December 2020

10.2165/00003495-200262170-00013

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1006539668

0 references

1 reference